Events & Presentations
Upcoming Events
There are currently no events to display.
Archived Events
-
May 8, 2018 at 8:30 AM EDT
First Quarter 2018 Investor Call
-
March 13, 2018 at 10:40 AM EDT
Cowen and Company 38th Annual Health Care Conference
Presentations
-
AACR 2018 Poster Kamoun et al; Targeting EphA2 in bladder cancer using a novel antibody-directed nanotherapeutic
-
AACR 2018 Poster Alkan et al; Understanding chemotherapy-induced replicative stress to identify rational combination therapies
-
AACR 2018 Poster Hass et al; Predicting ligand-dependent tumors from multi-dimensional signaling features
-
AACR 2018 Poster Tam et al; Development of TNF superfamily agonists 4-1BB ligand fusion shows anti-tumor activity in vivo
-
Corporate Overview
Corporate Overview 3 MB -
Article in Nature Communications: Estimation of immune cell content in tumour tissue using single-cell RNA-seq data
-
SABCS 2017 Poster Kaufman et al; SHERBOC: A Double-blind, Placebo-controlled, Phase 2 Trial of Seribantumab (MM-121) plus Fulvestrant in Heregulin Positive Metastatic Breast Cancer
-
AACR 2017 Poster Sawyer et al; Immunomodulatory effects of an EphA2-targeted Docetaxel antibody-directed nanotherapeutic and synergistic combination with PD-1 inhibitor
-
AACR 2017 Poster Kamoun et al; Mechanisms of synergy of carboplatin and an EphA2-targeted docetaxel antibody-directed nanotherapeutic
-
AACR 2017 Poster Shelker et al; Estimation of immune cell content in bulk tumor tissue using reference profiles from single-cell RNA-seq data
-
AACR 2017 Poster Yannatos et al; Dual-targeting of IGF-1R and ErbB3 Pathways in Ewing's Sarcoma Cellular Models with Istiratumab (MM-141), a Bispecific, Tetravalent Monoclonal Antibody
-
AACR 2017 Poster Dake et al; MM-161, A First-In-Class Pan-FGFR Antibody
